Omicron variant

2022.04.26

06:44

Omicron-specific Sinopharm COVID-19 vaccine approved for clinical trials in China

Asian Tech Press (Apr. 26) -- Sinopharm's COVID-19 vaccine candidate against Omicron variant got approval for clinical trials in China.

2022.01.25

13:01

Pfizer & BioNTech Initiate Clinical Trials on Vaccine Targeting Omicron

Asian Tech Press (Jan 25) -- Pfizer and BioNTech have reportedly launched clinical trials on a Covid-19 vaccine targeting the Omnicron strain. The two pharmaceutical companies said they began enrolling adults aged 18 to 55 in the United States and South Africa to examine the vaccine's safety, tolerability, and the immune response it produces.

2021.12.22

11:54

China's WestVac vaccine against Omicron to enter clinical trials in early 2022

Asian Tech Press (Dec 22) -- Chinese vaccine maker WestVac Biopharma Co., Ltd. announced Monday that its second-generation COVID-19 vaccine has high titers of neutralizing antibodies against the Omicron variant, and is expected to enter clinical trials in early 2022.

2021.12.13

08:41

China's Zhifei says its COVID-19 vaccine remains effective against Omicron

Asian Tech Press (Dec 13) -- Chinese vaccine maker Chongqing Zhifei Biological Products Co., Ltd. (Zhifei), its research unit said Monday that its recombinant COVID-19 vaccine remains effective against the Omicron variant.

07:58

Pfizer booster shot effective against Omicron, Israeli study shows

Asian Tech Press (Dec 13) -- A new Israeli study shows that a booster dose of the COVID-19 vaccine Comirnaty, which was co-developed by Pfizer Inc. and German company BioNTech SE, is effective against the Omicron variant, the Wall Street Journal reported Sunday.

2021.12.08

09:20

Pfizer-BioNTech COVID-19 vaccine less effective against Omicron, SA study shows

Asian Tech Press (Dec 8) -- The Omicron variant can partially evade protection from two doses of Comirnaty, the Pfizer-BioNTech COVID-19 vaccine, according to a new study from South Africa posted Tuesday.

2021.11.29

06:08

Moderna may launch vaccine against Omicron COVID-19 variant in early 2022

Asian Tech Press (Nov 19) -- U.S. pharmaceutical company Moderna Inc. said Sunday that it may launch a reformulated vaccine against the Omicron COVID-19 variant early next year.

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Tesla's (TSLA.O) shares fell as much as 5% in pre-market trading after its fourth-quarter deliveries fell short of expectations.
                            2025-01-02

                                    Tesla (TSLA.O) produced 22,727 other models in the fourth quarter, compared with market forecasts of 22,790.
                            2025-01-02

                                    Yunding Technology: The company currently has no self-owned AI hardware products for sale
                            2025-01-02

                                    Tesla (TSLA.O) Model 3/Y production in the fourth quarter of 2024 was 436,718 units.
                            2025-01-02

                                    Tesla (TSLA.O) shares fell 2.7% in pre-market trading.
                            2025-01-02